EL.En. S.p.A. (ELEAF)
OTCMKTS
· Delayed Price · Currency is USD
12.80
+0.10 (0.79%)
Jul 1, 2025, 12:14 PM EDT
EL.En. Revenue
EL.En. had revenue of 140.90M EUR in the quarter ending March 31, 2025, with 8.76% growth. This brings the company's revenue in the last twelve months to 577.19M, up 6.06% year-over-year. In the year 2024, EL.En. had annual revenue of 565.85M, down -1.76%.
Revenue (ttm)
577.19M EUR
Revenue Growth
+6.06%
P/S Ratio
1.70
Revenue / Employee
277.50K EUR
Employees
2,080
Market Cap
1.06B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 565.85M | -10.17M | -1.76% |
Dec 31, 2023 | 576.01M | -97.57M | -14.49% |
Dec 31, 2022 | 673.58M | 102.18M | 17.88% |
Dec 31, 2021 | 571.40M | 163.32M | 40.02% |
Dec 31, 2020 | 408.08M | 7.32M | 1.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 84.04M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |